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Abstract
BACKGROUND: Idiopathic thrombocytopenic purpura (ITP) still presents particular challenges for anesthetists, 
especially when the patient needs surgery. Preparing a patient with ITP in elective surgery is an advantage for 
anesthetists since it gives us time to prepare the patient properly. 
CASE REPORT: We present a case of a 36-year-old woman scheduled for an elective laparotomy due to an ovarian 
cyst. She had been diagnosed with ITP in 2015 and was admitted to the intensive care unit (ICU) for post-operative 
bleeding. 
CONCLUSION: Individual experience in elective surgery should lead anesthetists to a better judgment in emergency 
cases with ITP.
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Introduction
Idiopathic thrombocytopenic purpura (ITP) is a 
situation that can lead easily or excessive hemorrhage. 
The hemorrhage or bleeding results from abnormally 
low levels of platelets. It is also called immune 
thrombocytopenia and affects both children and adults. 
ITP is an autoimmune ailment characterized by a low 
platelet count and no abnormality found in the bone 
marrow. Those with ITP who underwent surgery are 
considered to have an increased risk for post-operative 
complications due to the low platelet count [1].
ITP presents in about 1–2 in every 10,000 
pregnancies and characterized by the presence of 
autoantibodies that bind to platelet antigens, destroys 
the platelets in the reticuloendothelial system causing 
thrombocytopenia [2]. The American College of 
Obstetrics and Gynecology (ACOG) stated that 
some elements are conventionally correlated with 
this disease: (1) Platelet count <100 × 103/uL with or 
without megakaryocytes, (2) the absence of other 
systemic conditions or drugs that are associated 
with thrombocytopenia, (3) a normal or increased 
medullary megakaryocytes, and (4) the absence of 
splenomegaly [3].
Case Presentation
A 65 kg, 36-year-old woman with a history of 
ITP was planned for an elective ovarian cyst removal 
procedure. She was scheduled for a similar procedure 
at another hospital before she was admitted to our 
hospital, but the blood transfusions were given never 
managed to get her platelet count up. She was first 
diagnosed with ITP in 2015, after a C-section surgery 
that caused her 1500 mL amount of bleeding, and she 
was admitted to the ICU for 3 days before she was 
transferred to a regular ward. She never experienced 
excessive bleeding after that but said that she easily 
gets bruises, especially on her extremities, which will 
resolve within days or a couple of weeks.
Her ITP history aside, she presented with 
normal findings except for her blood count. Two days 
before surgery, her CBC came back with white blood 
cell 12.29 × 103/µL, hemoglobin 11.5 g/dL, hematocrit 
36.4%, and platelet 9 × 103/µL. We gave 300 mL of 
fresh frozen plasma and 1000 mL of thrombocyte 
concentrate, and we retake the blood test 24 h after. The 
results came back as white blood cell 14.71 × 103/µL, 
hemoglobin 11.8 g/dL, hematocrit 37.6%, and platelet 
15 × 103/µL. Other laboratory results were bleeding time 
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(3 min), clotting time (12 min), prothrombin time (PT) = 
13.6 s, activated partial thromboplastin time (aPTT) = 
31.5 s, and INR 1.01.
Considered that, she did not respond as 
well during previous transfusions, we explained the 
situations to the patient and her family, and we decided 
to go on with the surgery. We prepared a subarachnoid 
block with a G27 spinal needle without introducer 
assistance.
Premedication used was 4 mg ondansetron, 
125 mg methylprednisolone, and 2 mg midazolam, 
all intravenously. While lying on her left side, we 
administered 12.5 mg of intrathecal 0.5% heavy 
bupivacaine without any additional medications. The 
surgery went uneventful except for 1300 mL bleeding 
without any drop in hemodynamics. During surgery, 
we administered a total of 1200 mL crystalloid and 
500 mL colloid, with 1000 mg tranexamic acid. After the 
surgery, she was transferred to ICU, received a 750 mL 
blood transfusion in 48 h, then she was discharged to 
ward. She was discharged home on the 4th day after the 
surgery and reported no complaints on her follow-up 
visit at the outpatient department.
Discussion
Perioperative hemorrhage in patients with low 
platelet counts presents a specific surgical challenge. 
The bleeding time of ITP patients is generally shorter 
compared to the severity of the thrombocytopenia, and the 
severity of bleeding in ITP is less than that encountered 
with equivalent degrees of thrombocytopenia in bone 
marrow failure. Several methods have been proposed 
to elevate the pre-operative platelet count to the “safe” 
level.
Severely low platelet count requires platelet 
transfusion before surgery. In advanced medical 
centers, IV immunoglobulins (IVIg) may be available. 
IVIg is an essential agent in the pre-operative period 
of an elective procedure, although this approach is not 
always practical [1]. IVIg that is given in a dose of 1 g/kg 
reduces platelet destruction [4]. A significant increase in 
the platelet count is usually not achieved until 2–3 days 
following initiation of therapy. IVIg is also useful in the 
post-operative period. Besides, its relatively high price, 
the possibility of its side effects (allergic response, liver 
dysfunction, etc.,) must also be considered.
Several authors reported various anesthesia 
management in thrombocytopenic patients, by both 
general [4], [5], [6], [7], [8] and regional [9] anesthesia. 
We approached this case by regional anesthesia 
for two reasons. First, the patient received a platelet 
transfusion before she was admitted to our hospital. Her 
platelet level was moving slightly 15,000/uL–21,000/uL 
and then went down to 11,000/uL. That means she 
was not responding well to platelet transfusion. She 
was diagnosed with an ovarian cyst which causing 
intermittent pain, and the pain was disturbing her quality 
of life. She went to seek help from a gynecologist in the 
hope that doctors will do something to alleviate the pain. 
Second, her coagulation profile was somehow returned 
to our satisfaction (PT 13.6 sec, aPTT 31.5 sec, and 
INR 1.01).
We prepared this case with a 1000 mL of PRCs 
and 1000 mL of platelet transfusions. We used a G27 
spinal needle to reduce the chance of encountering 
blood vessels during the subarachnoid block procedure 
that may create certain complications for the patient. 
The spinal needle was inserted without introducer 
for the same reason. Without it, the insertion was 
somewhat more difficult, of course, but considering the 
risks the needle brings to the patient, we thought that it 
was thoughtful.
General anesthesia may be a common option 
for such a case, but it is not without any potential 
complications. Given the fact that the patient was 
bruising easily in her daily life, there is always a 
chance that we will cause direct trauma to her airway 
during laryngoscopy. We all agreed that general 
anesthesia is not a bad choice for this case, but given 
her current coagulation status, we were assured that 
regional anesthesia is a safer option. Despite some 
recommendations stated that platelet count of <100 
is safe for spinal anesthesia, there is currently no 
consistent evidence of a safe platelet count for spinal 
anesthesia [10].
Conclusion
The administration of IVIg is not mandatory 
for the pre-operative management of ITP. Platelet 
transfusions are necessary for pre-operative 
management of emergency surgical treatment for 
patients with thrombocytopenia. Both PRC and 
platelet transfusions are essential to be prepared 
before surgery. Anesthetists should be able to manage 
ITP patients by both general or regional anesthesia. 
A thorough understanding of risks and benefits of both 
techniques may lead anesthetists to better judgment 
and, eventually, a safer and better outcome for the 
patient.
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